Advertisement
Screener

ASSERTIO THERAPEUTICS, INC. Operating Cash Flow

ASSERTIO THERAPEUTICS, INC. Operating Cash Flow

ASSERTIO THERAPEUTICS, INC. reported Operating Cash Flow of -$25.06 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-11.

Discontinued › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2020-05-11

  • ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2020-03-31 was -$25.06M, a 192.16% decline year-over-year.
  • ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2019-12-31 was $7.86M, a 50.16% decline year-over-year.
  • ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2019-09-30 was $33.91M, a 52.08% decline year-over-year.
  • ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2019-06-30 was $21.51M, a 66.29% increase year-over-year.
  • ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2019 was $90.47M, a 24.80% increase from fiscal 2018.
  • ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2018 was $72.50M, a 16.62% increase from fiscal 2017.
  • ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2017 was $62.17M, a 12.76% decline from fiscal 2016.
  • ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2016 was $71.26M, a 53.23% decline from fiscal 2015.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 month
2020-03-31-$25.06M
10-Q · filed 2020-05-11
-$17.21M
derived: sum of 2 quarters · filed 2020-05-11
$16.70M
derived: sum of 3 quarters · filed 2020-05-11
$38.22M
derived: sum of 4 quarters · filed 2020-05-11
2019-12-31$7.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10
$41.77M
derived: sum of 2 quarters · filed 2020-03-10
$63.28M
derived: sum of 3 quarters · filed 2020-03-10
$90.47M
10-K · filed 2020-03-10
2019-09-30$33.91M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$55.42M
derived: sum of 2 quarters · filed 2019-11-07
$82.62M
10-Q · filed 2019-11-07
$98.38M
derived: sum of 4 quarters · filed 2020-05-11
2019-06-30$21.51M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
$48.71M
10-Q · filed 2019-08-09
$64.47M
derived: sum of 3 quarters · filed 2020-05-11
$135.24M
derived: sum of 4 quarters · filed 2020-05-11
2019-03-31$27.20M
10-Q · filed 2020-05-11
$42.96M
derived: sum of 2 quarters · filed 2020-05-11
$113.73M
derived: sum of 3 quarters · filed 2020-05-11
$126.67M
derived: sum of 4 quarters · filed 2020-05-11
2018-12-31$15.76M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10
$86.53M
derived: sum of 2 quarters · filed 2020-03-10
$99.47M
derived: sum of 3 quarters · filed 2020-03-10
$72.50M
10-K · filed 2020-03-10
2018-09-30$70.77M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$83.71M
derived: sum of 2 quarters · filed 2019-11-07
$56.73M
10-Q · filed 2019-11-07
$84.00M
derived: sum of 4 quarters · filed 2020-03-10
2018-06-30$12.94M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
-$14.04M
10-Q · filed 2019-08-09
$13.22M
derived: sum of 3 quarters · filed 2020-03-10
$10.02M
derived: sum of 4 quarters · filed 2020-03-10
2018-03-31-$26.98M
10-Q · filed 2019-05-09
$287.00K
derived: sum of 2 quarters · filed 2020-03-10
-$2.92M
derived: sum of 3 quarters · filed 2020-03-10
$19.19M
derived: sum of 4 quarters · filed 2020-03-10
2017-12-31$27.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10
$24.06M
derived: sum of 2 quarters · filed 2020-03-10
$46.16M
derived: sum of 3 quarters · filed 2020-03-10
$62.17M
10-K · filed 2020-03-10
2017-09-30-$3.21M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09
$18.90M
derived: sum of 2 quarters · filed 2018-11-09
$34.91M
10-Q · filed 2018-11-09
$75.94M
derived: sum of 4 quarters · filed 2019-03-11
2017-06-30$22.11M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08
$38.11M
10-Q · filed 2018-08-08
$79.15M
derived: sum of 3 quarters · filed 2019-03-11
$96.43M
derived: sum of 4 quarters · filed 2019-03-11
2017-03-31$16.01M
10-Q · filed 2018-05-10
$57.04M
derived: sum of 2 quarters · filed 2019-03-11
$74.33M
derived: sum of 3 quarters · filed 2019-03-11
2016-12-31$41.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11
$58.32M
derived: sum of 2 quarters · filed 2019-03-11
$71.26M
10-K · filed 2019-03-11
2016-09-30$17.29M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$30.23M
10-Q · filed 2017-11-09
2016-06-30$12.94M
10-Q · filed 2017-08-07
2015-12-31$152.37M
10-K · filed 2018-03-01
2013-03-31-$4.87M
10-Q · filed 2013-05-09
-$10.59M
derived: sum of 2 quarters · filed 2013-05-09
-$10.99M
derived: sum of 3 quarters · filed 2013-05-09
-$24.34M
derived: sum of 4 quarters · filed 2013-05-09
2012-12-31-$5.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22
-$6.12M
derived: sum of 2 quarters · filed 2013-02-22
-$19.47M
derived: sum of 3 quarters · filed 2013-02-22
-$30.98M
10-K · filed 2013-02-22
2012-09-30-$402.00K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-05
-$13.75M
derived: sum of 2 quarters · filed 2012-11-05
-$25.27M
10-Q · filed 2012-11-05
-$40.00M
derived: sum of 4 quarters · filed 2013-05-09
2012-06-30-$13.35M
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-13
-$24.86M
10-Q/A · filed 2012-08-13
-$39.59M
derived: sum of 3 quarters · filed 2013-05-09
-$49.30M
derived: sum of 4 quarters · filed 2013-05-09
2012-03-31-$11.52M
10-Q · filed 2013-05-09
-$26.25M
derived: sum of 2 quarters · filed 2013-05-09
-$35.95M
derived: sum of 3 quarters · filed 2013-05-09
-$33.66M
derived: sum of 4 quarters · filed 2013-05-09
2011-12-31-$14.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22
-$24.43M
derived: sum of 2 quarters · filed 2013-02-22
-$22.15M
derived: sum of 3 quarters · filed 2013-02-22
$57.65M
10-K · filed 2013-02-22
2011-09-30-$9.70M
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-05
-$7.42M
derived: sum of 2 quarters · filed 2012-11-05
$72.38M
10-Q · filed 2012-11-05
$73.44M
derived: sum of 4 quarters · filed 2013-02-22
2011-06-30$2.29M
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-13
$82.08M
10-Q/A · filed 2012-08-13
$83.14M
derived: sum of 3 quarters · filed 2013-02-22
$83.35M
derived: sum of 4 quarters · filed 2013-02-22
2011-03-31$79.80M
10-Q · filed 2012-05-08
$80.85M
derived: sum of 2 quarters · filed 2013-02-22
$81.06M
derived: sum of 3 quarters · filed 2013-02-22
2010-12-31$1.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22
$1.26M
derived: sum of 2 quarters · filed 2013-02-22
-$2.38M
10-K · filed 2013-02-22
2010-09-30$206.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07
-$3.44M
10-Q · filed 2011-11-07
2010-06-30-$3.64M
10-Q · filed 2011-08-02
2009-12-31$1.84M
10-K · filed 2012-03-08